PlainRecalls
FDA Drug Moderate Class II Terminated

Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.

Reported: May 4, 2022 Initiated: April 6, 2022 #D-0788-2022

Product Description

Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.

Reason for Recall

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
433/30 count blister cards, 33/60 count blister cards
Distribution
Product was distributed to customers in AK and PA.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Losartan Potassium 50 mg Tablet, a) 30-count blister card (NDC# 70518-3282-1), b) 60-count blister card (NDC: 70518-3282-0), Rx Only, MFG by: Lupin Pharma, Baltimore, MD 21202.. Recalled by RemedyRepack Inc.. Units affected: 433/30 count blister cards, 33/60 count blister cards.
Why was this product recalled?
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 4, 2022. Severity: Moderate. Recall number: D-0788-2022.